• 
  Maya Hites, Clément Massonnaud, Eva Larranaga Lapique, Drifa Belhadi, Simon Jamard, et al.. Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy): A phase 3, randomized, double-blind, placebo-controlled trial. Journal of Infection, 2024, 88 (3), pp.106120. ⟨10.1016/j.jinf.2024.106120⟩. ⟨hal-04577427⟩
• 
  Fabienne El-Khoury, Meryl Puget, Christophe Leon, Enguerrand Du Roscoat, Annie Velter, et al.. Increased risk of suicidal ideation among French women: the mediating effect of lifetime sexual victimisation. Results from the nationally representative 2017 Health Barometer survey.. Archives of Women's Mental Health, 2020, 23 (5), pp.635-641. ⟨10.1007/s00737-020-01021-3⟩. ⟨inserm-04699646⟩
• 
  Idir Aniss Acherar. Détection et identification de Plasmodium falciparum sur des images microscopiques. Médecine humaine et pathologie. Sorbonne Université, 2024. Français. ⟨NNT : 2024SORUS019⟩. ⟨tel-04698420⟩
• 
  A. Thomas, S. Tran, L. El Houari, A. Seyve, F. Bielle, et al.. Prognosis of glioblastoma patients improves significantly over time interrogating historical controls. European Journal of Cancer, 2024, 202, pp.114004. ⟨10.1016/j.ejca.2024.114004⟩. ⟨hal-04627071⟩
• 
  Marie Gousseff, Pauline Penot, Laure Gallay, Dominique Batisse, Nicolas Benech, et al.. Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?. Journal of Infection, 2020, 81 (5), pp.816-846. ⟨10.1016/j.jinf.2020.06.073⟩. ⟨hal-03080302⟩
• 
  Alexandre Ramchandar Gomajee, Barry Katharine Michelle, Chazelas Eloi, Dufourg Marie-Noëlle, Barreto-Zarza Florencia, et al.. Early Childcare and Developmental Delay Risk at 3.5 Years: Insights from the French ELFE Cohort. European Journal of Pediatrics, 2024, Online ahead of print. ⟨10.1007/s00431-024-05742-w⟩. ⟨hal-04691583⟩
• 
  Cathia Soulié, Laurence Morand-Joubert, Jean-Michel Cottalorda, Charlotte Charpentier, Pantxika Bellecave, et al.. Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinant. Journal of Clinical Virology, 2018, 99-100, pp.57-60. ⟨10.1016/j.jcv.2017.12.014⟩. ⟨hal-01984179⟩
• 
  Amélie Guihot, Isabelle Plu, Cathia Soulié, Alice Rousseau, Cecilia Nakid-Cordero, et al.. Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection. Frontiers in Immunology, 2022, 13, pp.844727. ⟨10.3389/fimmu.2022.844727⟩. ⟨hal-03745734⟩
• 
  Nadine Tarantino, Elena Litvinova, Assia Samri, Cathia Soulié, Véronique Morin, et al.. Identification of natural killer markers associated with fatal outcome in COVID-19 patients. Frontiers in Cellular and Infection Microbiology, 2023, 13, pp.1165756. ⟨10.3389/fcimb.2023.1165756⟩. ⟨hal-04146051⟩
• 
  Elisa Teyssou, Stéphane Marot, Théophile Cocherie, Antoine Fauchois, Basma Abdi, et al.. Prolonged replication of BA.1 and BA.2 Omicron lineages compared to Delta variant in nasopharyngeal samples from COVID-19 patients. Infectious Diseases Now, 2022, ⟨10.1016/j.idnow.2022.10.001⟩. ⟨hal-03908405⟩
• 
  N Grellier, J Kirchgesner, M Uzzan, P Mclellan, C Stefanescu, et al.. Early ileal resection in Crohn's disease is not associated with severe long-term outcomes: The ERIC study. Alimentary Pharmacology and Therapeutics, 2024, ⟨10.1111/apt.18247⟩. ⟨hal-04691632⟩
• 
  Martin Martinot, Aude Jary, Samira Fafi-Kremer, Valentin Leducq, Heloise Delagreverie, et al.. Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019. Clinical Infectious Diseases, 2021, 73 (7), pp.e1762-e1765. ⟨10.1093/cid/ciaa1474⟩. ⟨hal-03704027⟩
• 
  Elisa Teyssou, Héloise Delagrèverie, Benoit Visseaux, Sidonie Lambert-Niclot, Ségolène Brichler, et al.. The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients. Journal of Infection, 2021, 83 (4), pp.e1-e3. ⟨10.1016/j.jinf.2021.08.027⟩. ⟨hal-03713074⟩
• 
  Romain Coppée, François Blanquart, Aude Jary, Valentin Leducq, Valentine Marie Ferré, et al.. Phylodynamics of SARS-CoV-2 in France, Europe, and the world in 2020. eLife, 2023, 12, ⟨10.7554/eLife.82538⟩. ⟨hal-04275646⟩
• 
  F. Pommeret, J. Colomba, C. Bigenwald, A. Laparra, S. Bockel, et al.. Bamlanivimab + Etesevimab Therapy Induces SARS-CoV-2 Immune Escape Mutations and Secondary Clinical Deterioration in COVID-19 Patients with B-cell Malignancies. Annals of Oncology, 2021, 32 (11), pp.1445--1447. ⟨10.1016/j.annonc.2021.07.015⟩. ⟨hal-03793520⟩
• 
  Joris Muller, Pierre Tran Ba Loc, Florence Binder Foucard, Aurélie Borde, Amélie Bruandet, et al.. Major interregional differences in France of COVID-19 hospitalization and mortality from January to June 2020. Epidemiology and Public Health = Revue d'Epidémiologie et de Santé Publique, 2022, 70 (6), pp.265-276. ⟨10.1016/j.respe.2022.08.008⟩. ⟨hal-03885736⟩
• 
  Marie-Lorraine Monin, Sophie Tezenas Du Montcel, Cecilia Marelli, Cécile Cazeneuve, Perrine Charles, et al.. Survival and severity in dominant cerebellar ataxias. Annals of Clinical and Translational Neurology, 2015, 2 (2), pp.202-207. ⟨10.1002/acn3.156⟩. ⟨hal-04688294⟩
• 
  Sophie Tezenas Du Montcel, Alexandra Durr, Peter Bauer, Karla P Figueroa, Yaeko Ichikawa, et al.. Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain - A Journal of Neurology , 2014, 137 (9), pp.2444-55. ⟨10.1093/brain/awu174⟩. ⟨hal-04688293⟩
• 
  Julien Kirchgesner, Shirley V. Wang, Sebastian Schneeweiss. Strengthening Real‐World Evidence on Question Not Answered by Randomized Trials: A Trial Calibration Approach. Pharmacoepidemiology and Drug Safety, 2024, 33 (9), ⟨10.1002/pds.70008⟩. ⟨hal-04687891⟩
• 
  Mélanie Deschasaux-Tanguy, Laurent Bourhis, Xavier Lamballerie, Fabrice Carrat, Mathilde Touvier. Body weight, body composition and the risk of SARS‐CoV‐2 infection in a large population‐based sample. Journal of Internal Medicine, 2021, 290 (6), pp.1268-1271. ⟨10.1111/joim.13364⟩. ⟨hal-03714174⟩

2 291

1 152